These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33049271)

  • 1. IL-13 Signaling in CD30
    Wen Y; Sun J; Yi S; Gao Y; Kouttab N; Morgan J; Wang Y; Kadin ME
    J Invest Dermatol; 2021 May; 141(5):1360-1363.e3. PubMed ID: 33049271
    [No Abstract]   [Full Text] [Related]  

  • 2. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?
    Collins K; Gu J; Aung PP; Nagarajan P; Curry JL; Huen A; Ivan D; Prieto VG; Tetzlaff MT; Duvic M; Miranda RN; Vega F; Torres-Cabala CA
    Virchows Arch; 2021 Aug; 479(2):377-383. PubMed ID: 33604757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive epidermotropic CD8+/CD4- primary cutaneous CD30+ lymphoproliferative disorder in a patient with sarcoidosis.
    Gelfand JM; Wasik MA; Vittorio C; Rook A; Junkins-Hopkins JM
    J Am Acad Dermatol; 2004 Aug; 51(2):304-8. PubMed ID: 15280854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma.
    Kleinhans M; Tun-Kyi A; Gilliet M; Kadin ME; Dummer R; Burg G; Nestle FO
    Blood; 2003 Feb; 101(4):1487-93. PubMed ID: 12393570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of primary cutaneous CD30+ T-cell lymphoproliferative disorder with features of granulomatous slack skin disease.
    Wada K; Maesawa C; Satoh T; Akasaka T; Masuda T
    Br J Dermatol; 2002 Nov; 147(5):998-1002. PubMed ID: 12410714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of primary cutaneous T-cell lymphomas.
    Slater DN
    Histopathology; 1995 Jan; 26(1):99-101. PubMed ID: 7713490
    [No Abstract]   [Full Text] [Related]  

  • 7. CD30-positive cutaneous T-cell lymphoma with concurrent solid tumour.
    Au WY; Yeung CK; Chan HH; Wong RW; Shek TW
    Br J Dermatol; 2002 Jun; 146(6):1091-5. PubMed ID: 12072086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: A clue to the pathophysiology of clinical regression.
    Mori M; Manuelli C; Pimpinelli N; Mavilia C; Maggi E; Santucci M; Bianchi B; Cappugi P; Giannotti B; Kadin ME
    Blood; 1999 Nov; 94(9):3077-83. PubMed ID: 10556192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Jak3 signaling in IL-17 expression in malignant cutaneous T-cell lymphoma.
    Kwatra SG
    J Invest Dermatol; 2011 Sep; 131(9):1954-5; author reply 1955-6. PubMed ID: 21614012
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis E virus-induced primary cutaneous CD30(+) T cell lymphoproliferative disorder.
    Mallet V; Bruneau J; Zuber J; Alanio C; Leclerc-Mercier S; Roque-Afonso AM; Kraft ARM; Couronné L; Roulot D; Wedemeyer H; Albert ML; Hillon P; Laroche L; Pol S; Hermine O
    J Hepatol; 2017 Dec; 67(6):1334-1339. PubMed ID: 28860025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.
    Bekkenk MW; Geelen FA; van Voorst Vader PC; Heule F; Geerts ML; van Vloten WA; Meijer CJ; Willemze R
    Blood; 2000 Jun; 95(12):3653-61. PubMed ID: 10845893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the t(2;5) (p23;q35) translocation in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.
    Wood GS
    Leuk Lymphoma; 1998 Mar; 29(1-2):93-101. PubMed ID: 9638979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment.
    Willemze R; Beljaards RC
    J Am Acad Dermatol; 1993 Jun; 28(6):973-80. PubMed ID: 8388410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous pleomorphic T-cell lymphoma expressing CD30 antigen.
    Gianotti R; Alessi E; Cavicchini S; Berti E
    Am J Dermatopathol; 1991 Oct; 13(5):503-8. PubMed ID: 1659246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent Oncogenic JAK and STAT Alterations in Cutaneous CD30-Positive Lymphoproliferative Disorders.
    Maurus K; Appenzeller S; Roth S; Brändlein S; Kneitz H; Goebeler M; Rosenwald A; Geissinger E; Wobser M
    J Invest Dermatol; 2020 Oct; 140(10):2023-2031.e1. PubMed ID: 32147503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD30 expression: a diagnostic pitfall for primary cutaneous gamma delta T cell lymphoma.
    Tang KHK; Au-Yeung R; Ting SH; Kwong YL
    Ann Hematol; 2021 Oct; 100(10):2653-2657. PubMed ID: 32860088
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients.
    Beljaards RC; Kaudewitz P; Berti E; Gianotti R; Neumann C; Rosso R; Paulli M; Meijer CJ; Willemze R
    Cancer; 1993 Mar; 71(6):2097-104. PubMed ID: 8382999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 Expression in Primary Cutaneous CD30-Positive Lymphoproliferative Disorders and Transformed Mycosis Fungoides.
    Mitteldorf C; Robson A; Tronnier M; Pfaltz MC; Kempf W
    Dermatology; 2015; 231(2):164-70. PubMed ID: 26111483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SATB1 Defines a Subtype of Cutaneous CD30
    Sun J; Yi S; Qiu L; Fu W; Wang A; Liu F; Wang L; Wang T; Chen H; Wang L; Kadin ME; Tu P; Wang Y
    J Invest Dermatol; 2018 Aug; 138(8):1795-1804. PubMed ID: 29510190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations.
    Geissinger E; Sadler P; Roth S; Grieb T; Puppe B; Müller N; Reimer P; Vetter-Kauczok CS; Wenzel J; Bonzheim I; Rüdiger T; Müller-Hermelink HK; Rosenwald A
    Haematologica; 2010 Oct; 95(10):1697-704. PubMed ID: 20511667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.